Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Comment by schemehatcheron Jan 15, 2014 3:59pm
188 Views
Post# 22095603

RE:The Wedbush Analyst Report

RE:The Wedbush Analyst Report
I don't think you're supposed to talk about that....but since you did.....

The CDN pricing has increased with recent weakness in Loonie

%5.45, $10.90 and $23.98 in CDN funds.

I know the two analysts ( Wade and Dean ) are listed on the Spectral website, but the reports are not, perhaps even Spectral has been left in the dark when it comes to these lofty targets.

I did see the new analyst ( Cormark ), show up as a buyer this AM, they seemed to be in the right place at the right time, as they were sold 178K at the open for .50.  I suppose that transaction would be more difficult if their target was in the $5 range.

Glad to see a poster willing to discuss a positive, hope you're not charged or suspended from Stockhouse for being overly optimistic.

Schemer

PS - It's a treat to have Sqr back, I'll just settle in and let him educate me.
Bullboard Posts